Neck News and Research

RSS

Researchers identify effects of nanoparticles on intestinal microorganisms

The intestinal microbiome is not only key for food processing but an accepted co-determinant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.

29 Jan 2019

Regular use of aspirin may help some patients survive head and neck cancer

Regular use of aspirin or other nonsteroidal anti-inflammatory drugs may help some patients with head and neck cancer survive the disease, according to a study led by Professor Jennifer Grandis at the University of California, San Francisco.

27 Jan 2019

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found.

25 Jan 2019

Study suggests link between keloids and high risk of breast cancer among African Americans

Findings from a new study conducted by researchers at Henry Ford Health System suggest a link between keloids and increased risk of being diagnosed with breast cancer, particularly among African Americans

25 Jan 2019

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2019 recipients of the Damon Runyon-Rachleff Innovation Award.

24 Jan 2019

Free screening for lung cancer can save money while building healthy relationship with patients

A free, simple screening for lung cancer can save a patient money, while building a healthy relationship for any medical needs they may have in the future.

24 Jan 2019

Transmissible cancer in Tasmanian devils unlikely to cause extinction, study reveals

A new study of Tasmanian devils has revealed that a transmissible cancer which has devastated devil populations in recent years in unlikely to cause extinction of the iconic species.

24 Jan 2019

Unique form of chronic sinusitis found in older patients

Older patients with a diagnosis of chronic sinusitis -- a disease of the nasal cavity and paranasal sinuses that often persists over many years -- have a unique inflammatory signature that may render them less responsive to steroid treatment, according to a new study published by Vanderbilt researchers.

23 Jan 2019

Scientists discover new blood vessels in bone

Researchers have discovered new blood vessels in the long bones of mice and similar new vessels in human long bones that could be used to further our understanding of osteoporosis.

23 Jan 2019

Physicians say eSport players should be treated as college athletes

With more than 80 US colleges offering varsity eSport teams, physicians writing in the British Journal of Medicine say collegiate players should be treated as athletes, with an appropriate level of medical care to promote continuing health.

23 Jan 2019

Scientists aim to find genetic causes of developmental abnormalities in the vagina and uterus

A percentage of females are born with a missing or underdeveloped vagina and uterus, and scientists are working to analyze the genes of hundreds of them to get a better idea about causes, improve genetic counseling and ideally treatment.

22 Jan 2019

Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma

Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.

18 Jan 2019

WTC first responders at higher risk for head and neck cancers, study finds

A Rutgers study has found a significant increase in head and neck cancers among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC), pointing to newly emerging risks that require ongoing monitoring and treatment of those who were exposed during the initial response.

17 Jan 2019

Neck-strengthening exercises can protect athletes from concussions

Rutgers researchers have proposed a solution for athletes at higher risk for sports-related concussions, such as football and soccer: Protect your head with neck-strengthening exercises in the pre-season.

17 Jan 2019

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKET™ immunotherapy drug candidates to patients in clinical trials beginning in 2019.

16 Jan 2019

Nerve transfer surgery restores arm movement in children with acute flaccid myelitis

An innovative and complex surgery involving nerve transfers is restoring hope and transforming lives torn apart by a mysterious and devastating illness. Acute flaccid myelitis, also known as AFM, strikes without warning, shows no mercy and frequently results in paralysis.

15 Jan 2019

Cancer patients are four times more likely to commit suicide

People with cancer are more than four times more likely to commit suicide than people without cancer, according to Penn State College of Medicine researchers.

14 Jan 2019

New biomarker may help better predict outcomes in patients with HPV-related head and neck cancers

By analyzing variations in the level of human papillomavirus (HPV) in head and neck cancers, researchers at The University of Texas MD Anderson Cancer Center have discovered a gene signature associated with treatment response and survival in patients.

10 Jan 2019

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

7 Jan 2019

Hearing challenges still reported by high proportion of older people with hearing aids

A high proportion of older people with hearing aids, especially those with lower incomes, report having trouble hearing and difficulty accessing hearing care services, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

7 Jan 2019

Neck News and Research

Researchers identify effects of nanoparticles on intestinal microorganisms

Regular use of aspirin may help some patients survive head and neck cancer

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Study suggests link between keloids and high risk of breast cancer among African Americans

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Free screening for lung cancer can save money while building healthy relationship with patients

Transmissible cancer in Tasmanian devils unlikely to cause extinction, study reveals

Unique form of chronic sinusitis found in older patients

Scientists discover new blood vessels in bone

Physicians say eSport players should be treated as college athletes

Scientists aim to find genetic causes of developmental abnormalities in the vagina and uterus

Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma

WTC first responders at higher risk for head and neck cancers, study finds

Neck-strengthening exercises can protect athletes from concussions

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

Nerve transfer surgery restores arm movement in children with acute flaccid myelitis

Cancer patients are four times more likely to commit suicide

New biomarker may help better predict outcomes in patients with HPV-related head and neck cancers

MD Anderson Cancer Center and Nanobiotix collaborate to expand clinical development of NBTXR3

Hearing challenges still reported by high proportion of older people with hearing aids

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News